Knowledge Palette, Inc.

10:45 AM - 11:00 AM (PDT), Wednesday, June 15, 2022
■Knowledge Palette is a Japanese biotech company conducting phenotypic drug discovery, biomarkers identification, and cell manufacturing optimization based on the world's best whole transcriptome technology through collaborative research with pharmaceutical companies.
■We analyze whole gene expression profiles of cells treated with broad spectrum of new drug candidates or culture media, and screen their effects by detecting influences on pathways in cells comprehensively based on our single-cell and large-scale transcriptome analysis technologies.
■Our single cell transcriptome analysis technology, ‘Quartz-Seq2’, was ranked as No.1 on both accuracy scores and overall scores in the Human Cell Atlas project (Mereu, et al. Nature Biotechnology (2020)
).
■We also developed high-throughput bulk transcriptome technology which can analyze a large variety of bulk samples simultaneously at less than a tenth the cost of existing technology (~$50 per sample).
Company Type:
Privately Funded Company
Company HQ State:
Not Provided
Company HQ Country:
Japan
Year Founded:
2018
Main Therapeutic Focus:
Lead Product in Development:
None
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
CEO
Knowledge Palette